Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1990 | 12-1989 | 12-1988 | 12-1987 | 12-1986 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 13,993 | 17,013 | 17,374 | 13,744 | 14,717 |
| TOTAL | $13,993 | $17,013 | $17,374 | $13,744 | $14,717 |
| Non-Current Assets | |||||
| PPE Net | 449,229 | 420,976 | 357,108 | 311,106 | 280,255 |
| Investments And Advances | 2,932 | 3,201 | 3,143 | 3,327 | 3,824 |
| Other Non-Current Assets | 13,832 | 9,301 | 7,862 | 7,741 | 4,859 |
| TOTAL | $465,993 | $433,478 | $368,113 | $322,174 | $288,938 |
| Total Assets | $479,986 | $450,491 | $385,487 | $335,918 | $303,655 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 77,779 | 31,503 | 58,926 | 36,108 | 29,783 |
| Accounts payable and accrued liabilities | 20,100 | 22,904 | 27,515 | 22,768 | 24,193 |
| Accrued Expenses | 6,231 | 5,952 | 3,858 | 3,543 | 3,015 |
| TOTAL | $124,624 | $90,721 | $101,375 | $78,578 | $88,841 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 17,343 | 0 | 0 | 0 |
| TOTAL | $59,653 | $53,803 | $49,823 | $48,173 | $45,719 |
| Total Liabilities | $184,277 | $144,524 | $151,198 | $126,751 | $134,560 |
| Shareholders' Equity | |||||
| Common Shares | 111,360 | 27,132 | 27,040 | 112,721 | 107,629 |
| TOTAL | $111,360 | $35,606 | $35,533 | $112,721 | $107,629 |
| Total Liabilities And Equity | $295,637 | $180,130 | $186,731 | $239,472 | $242,189 |